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S
urface-enhanced Raman scattering
(SERS) spectroscopy is an ultra-sensitive
and ultra-rapid analytical technique that
can achieve detection limits down to the
single molecule level thanks to nanoplasmo-
nic effects.1,2 As a vibrational spectroscopy
technique, SERS can provide detailed infor-
mation about the structure and conforma-
tion of a molecular target, which has been
used to identifymolecules, proteins and their
mutual interactions.3 A major advantage of
SERS is that it can be performed under
physiological conditions, thereby preserving
the active state of proteins and revealing
protein kinetics and dynamics. SERS does
not require high protein concentrations as
is the case for NMR or X-ray crystallography
and it can be applied without prior knowl-
edge of the structure of the protein.4 Hence,
SERS has emerged as an attractive analytical
tool to investigate proteinprotein and
proteinligand interactions.5,6
In Gram-negative bacteria, quorum
sensing (QS) is mostly achieved through
the biosynthesis and sensing of N-acyl
L-homoserine lactones (acyl-HSLs) by LuxI/
R-type QS protein receptor systems.7,8 In
such QS circuits, LuxI-type synthases cata-
lyze the production of acyl-HSLs that freely
diffuse into and out of cells, where they bind
LuxR-type proteins that serve as signal re-
ceptors. When acyl-HSLs reach a threshold
concentration, the acyl-HSL-LuxR complex
activates the expression of QS-dependent
genes. Biochemical and structural studies
have shown that LuxR homologues are
homodimers, and each monomer folds into
two functional domains: an amino-terminal
ligand-binding domain (LBD) and a carbox-
yl-terminal DNA-binding domain (DBD),
joined by a short linker region. The cognate
ligand binds to a narrow cavity in the LBD,
formed by a cluster of hydrophobic and
aromatic residues, and it is believed that
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ABSTRACT Many members of the LuxR family of quorum sensing (QS)
transcriptional activators, including LasR of Pseudomonas aeruginosa, are believed
to require appropriate acyl-homoserine lactone (acyl-HSL) ligands to fold into an
active conformation. The failure to purify ligand-free LuxR homologues in
nonaggregated form at the high concentrations required for their structural
characterization has limited the understanding of the mechanisms by which QS
receptors are activated. Surface-enhanced Raman scattering (SERS) is a vibrational
spectroscopy technique that can be applied to study proteins at extremely low concentrations in their active state. The high sensitivity of SERS has allowed
us to detect molecular interactions between the ligand-binding domain of LasR (LasRLBD) as a soluble apoprotein and modulators of P. aeruginosa QS. We
found that QS activators and inhibitors produce differential SERS fingerprints in LasRLBD, and in combination with molecular docking analysis provide
insight into the relevant interaction mechanism. This study reveals signal-specific structural changes in LasR upon ligand binding, thereby confirming the
applicability of SERS to analyze ligand-induced conformational changes in proteins.
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this triggers a conformational change in the poly-
peptide, presumably enabling the binding of the
protein to specific promoters, ultimately leading to
transcriptional activation of QS genes.9,10 Despite of
the availability of a wealth of information, the precise
molecular mechanisms of LuxR receptor activation
still remain mostly unknown. This is largely due to
the failure to purify the relevant regulators in non-
aggregated form outside the cellular environment,
in the absence of an appropriate acyl-HSL.
Much of the information regarding acyl-HSL-
regulated QS systems has been obtained through the
study of Pseudomonas aeruginosa bacteria. P. aeruginosa
contains two pairs of LuxI/LuxR-type systems, termed
LasI/LasR and RhlI/RhlR. LasI and RhlI are synthases that
catalyze production of N-(3-oxododecanoyl)-homoserine
lactone (C12-HSL) and N-(butyryl)-homoserine lactone
(C4-HSL), which are sensed by the LasR and RhlR trans-
criptional receptors, respectively.11,12 LasR is known
to initiate the QS regulatory system in this bacterial
species,13 and therefore, it has attracted significant
interest as a target for QS modulation.1416 The X-ray
structure of the LBD of LasR forming a complex with
its natural ligand C12-HSL17 (Figure 1A) revealed a sym-
metric homodimer with the molecule buried in a pocket
enclosed by R-helices (R3, R4 and R5) and the concave
side of the central β-sheet of each LBD.17,18
We demonstrate in this paper the application of
SERS spectroscopy, combined with structural analysis,
molecular docking studies and assays of biological
activity, to detect molecular interactions between LasR
anddiverse activators and inhibitors of P. aeruginosaQS.
To this end the LBD of LasR (LasRLBD) bearing a
hexahistidine (6His) tag and a cysteine in its carboxyl-
terminus was expressed and purified in a soluble,
ligand-free (i.e., apoprotein) active form. Oriented at-
tachment of the polypeptide onto plasmonic gold
nanoparticle thin films and label-free SERS allowed us
to detect structural changes of LasRLBD as a result of
its interaction with cognate C12-HSL ligands, C4-HSL
agonists and Furanone C30 or acetylsalicylic acid (SA)
antagonists. Remarkably, highly sensitive and reprodu-
cible SERS spectra allowed us to discriminate between
activators and inhibitors of QS, through distinctive
vibrational features. Our study thus provides insight
into the molecular interactions between LasR and
modulators of P. aeruginosa QS, while featuring SERS
as a powerful tool for the dynamic study and screening
of proteinligand interactions.
RESULTS AND DISCUSSION
Expression of Apo LasRLBD and Analysis of Functional Activity.
We schematically show in Figure 1 the lactone-binding
domain (LBD) and the DNA-binding domain (DBD) of
LasR. To carry out the SERS investigation of conforma-
tional changes in LasR upon ligand interaction, we
focused on the LBD region of the protein as the DBD
is not required for ligand binding activity.17,19 There-
fore, the LBD of lasR gene, coding from amino-acids
encompassing Met-1 to Lys-173,17 was PCR amplified
from the pMHLAS plasmid20 and cloned into the
pET21a(þ) vector in frame with a 6His tag for affinity
purification and a C-terminal cysteine that is known
to strongly bind onto gold surfaces through the
Figure 1. (A) Co-crystal structure of LasRLBD (green) bound to C12-HSL (red) (PDB identity code 2UV0). The amino (N-) and carboxy
(C)-terminal regions of the polypeptide are indicated. (B) Schematic representation of full-length LasR and the corresponding LBD
bearing a hexahistidine-tag (6His) and a C-terminal cysteine (Cys). (C) SDS-PAGE and Coomassie blue staining of LasRLBD expression
andpurification.Lane1,uninduced total fraction; lane2, IPTG-induced total fraction; lane3, IPTG-inducedsoluble fraction; lane4,affinity
chromatography flow-through; lane 5, eluted protein. (D) Cross-linking assay of LasRLBD. The polypeptide expressed in bacteria in the
absence (lanes13) or in thepresence (lanes46) ofC12-HSLwas solubilized (S), affinitypurifiedand subjected tocrosslinking (+)with
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formation of AuS bonds (Figure 1B). The resulting
construct, termed pET21-LasRLBD, was transformed
in Escherichia coli BL21(DE3)pLysS cells for protein
expression. E. coli bacteria have been widely used
as suitable hosts to study the influence of different
acyl-HSLs in the expression of LuxR homologues as
they do not produce acyl-HSLs endogenously.9
The SERS study of the interactions of apo LasRLBD
with QS modulators required the expression and
purification of the polypeptide in the absence of its
cognate C12-HSL ligand. However, it has been shown
that overexpression of recombinant LuxR homologues
in E. coli without the appropriate signaling mole-
cules in the bacterial growth medium renders these
proteins insoluble and prone to degradation by cellular
proteases.9,17 Therefore, we first assessed the stability
and solubility of the LasRLBD polypeptide produced
in E. coli BL21(DE3)pLysS bacteria grown without C12-
HSL ligand (see Materials and Methods). Briefly, bacte-
rial cultures in log phase (OD6000.6) were induced
with 0.5 mM isopropyl β-D-1-thiogalactopyranoside
(IPTG) at 28 C for 4 h and then total proteins and
soluble protein fractions were separated on a 12%
sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) under reducing conditions and
stained with Coomassie Blue. As shown in Figure 1C,
a protein band with the expected molecular weight
corresponding to LasRLBD (∼19 kDa) can be seen
in the total protein extract from IPTG-induced cells
(Figure 1C, lane 2) but not in the total protein extract
from uninduced cells (Figure 1C, lane 1). The expres-
sion of LasRLBDwas also confirmedbyWestern blot and
immunostaining with anti-His tag antibodies (data not
shown). Importantly, apo LasRLBD was found in the
soluble fraction (Figure 1C, lane 3), which allowed us to
purify it upon elution from a nickel resin (Figure 1C,
lane 5). Similar levels of apo LasRLBD relative to the rest
of proteins in the soluble fraction (Figure 1C, lane 3)
and in the total protein extract (Figure 1C, lane 2),
suggested that the polypeptide was highly soluble.
The amount of soluble apo LasRLBD (Figure 1D, lane 1)
was similar to that obtained from bacteria grown in the
presence of the C12-HSL ligand (Figure 1D, lane 4),
again confirming that the polypeptide is stable and
soluble in its apoprotein form. Importantly, increasing
either the expression of apo LasRLBD or its concentra-
tion resulted in decreased solubility (data not shown).
Dimerization of LasR, as well as other LuxR-type
receptors, is a requisite for transcriptional activation
of target QS genes.21,22 The oligomeric state of apo
LasRLBD was assessed by chemical cross-linking with
disuccinimidyl suberate (DSS), which is a commonly
used strategy for the characterization of dimers of LuxR
homologues.2325 To this end, affinity purified LasRLBD
obtained from IPTG-induced BL21(DE3)pLysS bacteria
grown in the presence or in the absence of C12-HSL
was cross-linked with DSS and analyzed by SDS-PAGE.
As shown in Figure 1D, cross-linked dimeric complexes
of LasRLBD were detected at similar levels regardless
of the presence (lane 6) or absence (lane 3) of the
ligand, indicating that LasRLBD does exist in the form
of homodimers even when no C12-HSL is present. We
then investigated the activity of purified apo LasRLBD as
a quorum-quencher of C12-HSLmolecules, by employ-
ing an E. coli MT102 biosensor strain harboring the
pMHLAS reporter system that expresses green fluor-
escent protein (GFP) upon activation of LasR by exo-
genous addition of C12-HSL20 (Supporting Information
Figure S1). We hypothesized that functional LasRLBD
would sequester extracellular C12-HSLs, reducing the
levels of free ligand that would be available for binding
and activating intracellular LasR, resulting in decreased
GFP expression (Supporting Information Figure S1).
To test this hypothesis, C12-HSL was preincubated
with either affinity purified LasRLBD or BSA for 1 h,
and the mixtures were subsequently added to liquid
cultures of E. coliMT102 bacteria bearing pMHLAS and
further incubated for 90 min to allow GFP expression.
The expression of GFP was then evaluated by epifluor-
escence microscopy and quantified by fluorescence
spectroscopy. As shown in Figure 2, the preincubation
of C12-HSL (0.5 nmol) with apo LasRLBD significantly
reduced the levels of GFP whereas preincubation with
BSA (0.5 nmol) as a control did not affect GFP expres-
sion. This indicated that apo LasRLBD did indeed bind
C12-HSLs, preventing full induction of the acyl-HSL
reporter system.
A first conclusion of this study is thus related to the
general belief that LasR and other LuxR family mem-
bers require the presence of appropriate acyl-HSL
molecules to properly fold into their active conforma-
tions, which is mostly based on the production of large
amounts of soluble and stable protein upon supple-
menting the bacterial growth medium with cognate
acyl-HSLs. This strategy has been widely applied to-
ward the biochemical and structural characterization
of several LuxR homologues including LasR,22 TraR21,26
or QscR.27 This idea has been however challenged
by several groups,28,29 who provided experimental
evidence demonstrating that LasR folds into an
active conformation in the absence of C12-HSLs and
can remain in a properly folded signal-free state.
Our results indeed confirm these findings as we de-
monstrate that LasRLBD can be produced as a soluble,
dimeric and functional protein in extracts of bacteria
that were grown in the absence of cognate C12-HSL
ligands.
LasR Modulation by QS Activators and Inhibitors. C4-HSL is
the natural signaling ligand of P. aeruginosa RhlR QS
receptor, and it has been shown to slightly activate
the expression of a LasR-dependent lasB-lacZ transla-
tional fusion in E. coli.30 On the other hand, Furanone
C30 and SA are synthetic compounds that inhibit LasR
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acyl-HSL binding pocket of LasR as shownbymolecular
modeling studies.11,32,33 We analyzed the activity of
these LasR modulating compounds by means of the
E. coli MT102 biosensor bearing pMHLAS. A liquid
culture of E. coli containing pMHLAS plasmid was
divided into several subcultures, and incubated with
C4-HSL, Furanone C30 or SA at different concentrations
for 20 min. Subsequently, they were either treated or
untreated with C12-HSL for 90 min, as explained in the
Materials and Methods section, and GFP expression
was determined by fluorescence spectroscopy. As
shown in Figure 3B, C4-HSL was capable to induce
GFP expression, though to a lesser extent than C12-
HSL, demonstrating an agonistic activity over LasR. On
the other hand, SA and Furanone C30 displayed strong
inhibitory effects on GFP expression, while not affect-
ing bacterial growth (not shown), which confirms their
role as LasR antagonists.
SERS Analysis of Apo LasRLBD. The SERS substrate was
a gold nanoparticle thin film fabricated using polyelec-
trolyte layer-by-layer (LbL) assembly, by means of alter-
nate deposition of a positively charged polyelectrolyte,
poly(diallyldimethylammonium chloride) (PDDA), and
negatively charged, citrate-stabilized Au NPs (60 nm
diameter), on a glass slide. The resulting LbL film
comprising three bilayers (PDDA-Au NPs) displayed a
long-range uniform Au deposition (Supporting Informa-
tion Figure S2), displaying a broad extinction band
centered at 850 nmdue to significant plasmon coupling
and a less intense band at around 550 nm from single
particles.34 Since nonspecific binding of LasRLBD to the
Au nanoparticle surface would lead to nonhomogenous
SERS signals, a cysteine amino acid was genetically
introduced at the C-terminus of the polypeptide, im-
mediately after the hexa-histidine tag. The high affinity
toward Au-thiol binding has been widely employed
for site-directed attachment of functional antibody
fragments, enzymes or proteins on Au surfaces.35,36
In addition, the hexa-histidine tag has been reported
to bind the polypeptide to gold surfaces through
metal-histidine coordination.37 Thus, the attachment
of LasRLBD onto the Au nanoparticle-based sub-
strate should take place through its C-terminus, placing
the polypeptide in the conformation illustrated in
Figures 1A and 5. As shown in Figure 4, highly repro-
ducible SERS spectra were obtained, most likely due
to the targeted binding of LasRLBD to the gold surface.
The main features of the SERS spectra were assigned
according to the existing literature (Table 1). The SERS
spectra (Figure 4) display the characteristic feature
of AuS vibrational mode at 386 cm1 confirming the
specific interaction between the C-terminal cysteine
and the Au surface.38 In addition, the spectra show
vibrational bands that could also be assigned to this
amino acid (448, 690, and 788 cm1) and to thehistidine
Figure 2. (A) Fluorescence microscopy images of MT102/pMHLAS bacteria treated with C12-HSL previously incubated with
either LasRLBD or BSA, as labeled. Upper and lower panels showDAPI staining of bacteria andGFP expression, respectively. (B)
Induction of GFP expression from pMHLAS in E. coliMT102 after incubation of bacteria with C12-HSL or C12-HSL and LasRLBD
polypeptide. Error bars represent standard deviation calculated for three independent experiments.
Figure 3. (A) Compounds used in LasR modulation
studies:N-3-oxododecanoyl-homoserine lactone (C12-HSL),
N-butyryl-homoserine lactone (C4-HSL, C4), acetylsalicylic
acid (SA) and 4-bromo-5-(bromomethylene)-2(5H)-fura-
none (C30). (B) Evaluation of GFP expression from pMHLAS
in E. coliMT102 bacteria upon incubation with the indicated
amounts of C4, SA or C30 and subsequently treated without
(white bars) or with (gray bars) C12-HSL. The mean from
at least two independent experiments was normalized to




COSTAS ET AL. VOL. 9 ’ NO. 5 ’ 5567–5576 ’ 2015
www.acsnano.org
5571
amino acid (1099, 1439, and 1578 cm1) abundantly
present in the hexa-histidine tag.39 The targeted attach-
ment of LasRLBD orients the L3 loop toward the Au
surface (Figure 5). Therefore, the following vibrational
bands can be ascribed to amino acids present in the L3
loop and in its vicinity, such as Tyr-47 (peaks at 830,
1178, 1260, and 1537 cm1), Phe-167 (peaks at 1000,
1028, and 1178 cm1), Asp-43, Asp-46 and Glu-48, 124,
and 168 (peaks at 944 and 1439 cm1).3943 Further-
more, the enhancement ofmodes corresponding to the
asymmetric stretching of CCRN (1142 cm1) suggests
interactions of nitrogen atoms in histidine, arginine,
lysine or glutamine amino-acids with the gold surface.39
The intense peak at 1325 cm1 can be assigned to
an amide III (in phase combination of the NH
bending and CH stretching vibrations).39 We con-
firmed that the SERS spectral peaks shown in Figure 4
were characteristic of LasRLBD, as neither the buffer nor
the gold nanoparticle substrate produced significant
Raman signals (data not shown). Importantly, SERS
spectra recorded at 1, 3, and 6 h after binding the
polypeptide to the gold substrate did not show any
significant changes, thus proving that the protein is
stable under the assay conditions (Supporting Informa-
tion Figure S3).
Detection of Interactions between LasRLBD and QS Modulators
by SERS. SERS was then used to analyze whether
incubation of apo LasRLBD with either its cognate
C12-HSL or with agonist C4-HSL ligands can induce
conformational changes in the polypeptide. We at-
tached apo LasRLBD (ca. 0.5 nmol in 10 mM sodium
phosphate buffer at pH 8.0, PB buffer) to the Au
nanoparticle-based substrate, followed by incubation
with C12-HSL or C4-HSL (100 μM). As shown in Figure 6,
Figure 4. SERS spectra of apo LasRLBD measured in three
different regions of a gold nanoparticle-based substrate.
Excitationwith a 785 nm laser linewas used to avoid protein
damage.
TABLE 1. Experimental Vibrational Frequencies (cm1) for















1439 His, Glu, Lys
1537 Tyr
1578 NH and NH3þ def.
Figure 6. SERS spectra (after baseline correction) of
LasRLBD polypeptide incubated with C12-HSL, C4-HSL, SA
or Furanone C30. The green, red, and blue areas indicate
common, inhibitor-specific, and activator-specific SERS
fingerprints, respectively. Illumination with a 785 nm laser
line was used to avoid protein damage.
Figure 5. Schematic representation of possible contact
points between LasRLBD and a gold surface. Side (A) and front
(B) view of LasRLBD (PDB identification code 2UV0). High-
lighted are relevant structural features (R3, R4, R5, 310-helix,
L3 loop) and interacting amino acids: Lys-42 (light blue),
Asp-43 (orange), Gln 45 (red), Asp-46 (orange), Tyr-47 (blue),
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the SERS spectra of LasRLBD forming a complex with
either C12-HSL or C4-HSL, resemble that of ligand-
free LasRLBD but display some remarkable differences:
reduction in SERS intensity at 448, 690, and 788 cm1
corresponding to the C-terminal cysteine and ap-
pearance of additional peaks at 408, 1405 and
1630 cm1. The peak at 408 cm1 was assigned to
the deformation of the CN vibrational mode,40
whereas the 1630 cm1 band was assigned to an
Amide I peak characteristic of a relatively uncommon
secondary structure called the 310-helix.
44,45 Interest-
ingly, LasRLBD possesses a 310-helix conformed by the
amino acids from Gly-68 to Arg-71, which follows the
L3 loop (Figure 5) and has been shown to participate
in the lactone-binding pocket.17 Finally, the band
at 1405 cm1 was assigned to the COO symmetric
vibration of aspartic and glutamic amino acids, both
present in the L3 loop and 310-helix (Figure 5).
43 As
neither C12-HSL nor C4-HSL or the PB buffer produced
any significant SERS signals at the concentration used
in the binding assay when tested separately (data not
shown), we can state that, the observed peaks are
protein-specific. Altogether, these results show that
incubation of apo LasRLBD with both QS activators
gives rise to changes in the vibrational SERS spectra
of the polypeptide, thereby indicating conformational
changes linked to ligand interaction.
Analysis of the interactions of LasRLBD with SA
(100 μM) and Furanone C30 (10 μM) antagonists
(Figure 6) showed changes in the SERS spectra, which
were similar to those obtainedwith the acyl-HSLs, such
as the appearance of the CN stretching at 408 cm1
and the decrease of the cysteine peaks at 448, 690, and
788 cm1. Additionally, the LasR antagonists induced
a new peak at 1267 cm1, assigned to CdO stretching
vibrations of an R-helix,46 which was not observed
for C12-HSL or C4-HSL. This specific SERS signal could
be attributed to movements of the R-helices R3, R4
and/or R5, which constitute the ligand-binding pocket
(Figure 5). Importantly, the antagonists did not induce
the 1405 and 1630 cm1 peaks associated with struc-
tural movements involving the L3 loop and the
310-helix, thus confirming these SERS signals as signa-
tures of the QS activators. SA was not detected by SERS
on bare gold nanoparticle substrates at the concentra-
tion used in the binding assay (data not shown). On the
other hand, Furanone C30 did yield strong SERS signals
when analyzed separately (Supporting Information
Figure S6). Interestingly, the SERS peaks corresponding
to Furanone C30 itself were not detected upon incuba-
tion with LasRLBD, indicating that it did not reach the
gold surface in the presence of the polypeptide, likely
due to binding to LasRLBD. Finally, SERS measurements
performed at 1, 3, and 6 h yielded similar spectra for
each group of QS modulators (Supporting Informa-
tion Figures S4 and S5) demonstrating the reliability
of the data. These experiments also revealed that
conformational changes in LasRLBD were evident within
the first hour of incubation. The results, summarized in
Table 2, clearly show SERS detection of structural
changes in LasRLBD, associatedwith interactions of both
activators and inhibitors of QS, and that each group of
QS modulators produced specific SERS fingerprints.
Molecular Docking analysis of LasRLBDLigand Interactions.
Molecular docking analysis was used to study the
binding mode of C4-HSL, SA and Furanone C30 to
LasRLBD, so as to obtain an insight into their functional
roles as QS modulators. These studies were carried
out using the program GOLD (version 5.2) and the
protein geometries found in the crystal structure of the
LasRLBD/C12-HSL binary complex (PDB identification
code 2UV0). C12-HSL was initially docked as a control
and the result compared to the PDB entry 2UV0. The
efficacy of a compound to activate LasR was directly
correlated with its ability to maintain the binding
interactions observed in the LasRLBD/C12-HSL binary
complex (Figure 7A). As illustrated in Figure 7B, the
binding mode of the agonist C4-HSL is similar to that
of the natural ligand as it retains most of the binding
interactions of the homoserine lactone and amide
moieties of C12-HSL, including four intermolecular
hydrogen bonds involving Tyr-56, Trp-60, Asp-73
and Ser-129, CHΠ interactions with Trp-88 and a
lipophilic contact with Ala-105. Interestingly, despite of
the different lengths of their acyl chains, the two QS
activators did not show any significant distinct SERS
signals. This suggests that the molecular interactions
of C12-HSL and C4-HSL with the recognition center
of LasRLBD detected by SERS mainly depend on the
homoserine lactonemoieties. On the other hand, it has
been proposed that exposure of buried hydrophobic
residues in the lactone-binding pocket to the bulk
solvent could be responsible for protein instability
and degradation within the cell.18 Therefore, as
C4-HSL lacks a full-length acyl chain it cannot meet
most of the hydrophobic interactions established by
C12-HSL (cf. Figures 7A and 7B), thus explaining why
the noncognate C4-HSL molecule is not able to sustain
full activation of LasR (Figure 3B).
Regarding LasR antagonists, molecular docking
analysis revealed that both SA (Figure 7C) andFuranone
TABLE 2. SERS Fingerprints of LasRLBD upon Binding to
C12-HSL or C4-HSL (QS Activators) and SA or Furanone
C30 (QS Inhibitors)
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C30 (Figure 7D) would establish similar polar contacts
with the lactone-binding pocket of LasRLBD, involving
Tyr-56, Trp-60, Thr-75 and Arg-61 residues. Small differ-
enceswere however observed in the lipophilic contacts
of both ligands, in particular involving Leu-110,
Val-76 and Ala-127 residues. The shared topology may
be responsible for inducing similar SERS spectra as
experimentally observed (Figure 6). Although each
compound (Figure 7C,D) seemed to establish some of
the strongest contacts predicted for the homoserine
lactone moieties (Figure 7B), the type of chemical
interactions and their respective strengths were dif-
ferent (Supporting Information Table S1), which may
explain their inhibitory effect on LasR signaling
(Figure 3B). We speculate that SA and Furanone C30
do not establish contacts with key amino-acid residues
in LasRLBD, thus failing to properly stabilize the poly-
peptide, which would result in an accelerated proteo-
lytic degradation. Indeed, it has been reported that the
half-life of LuxR protein ofVibrio fischeri is reducedup to
100-fold in the presence of Furanone C30, suggesting
that furanones control expression of acyl-HSL-depen-
dent QS by destabilizing LuxR.31 Muh and co-workers
used ultrahigh-throughput screening to search for in-
hibitors in a library of 200 000 compounds. The screen-
ing identified triphenyl (TP) compounds that are
structurally different from acyl-HSLs, bearing either
agonist or antagonist activity of the LasR-dependent
fluorescent reporter. In silico docking studies suggested
that hydrogen bond interactions of these molecules
with Trp-60 and Asp-73 influenced whether the TP
compounds act as an agonist or an antagonist.9 The
authors indicated that only those molecules establish-
ing contacts with both Trp-60 and Asp-73 function
as agonists. Interestingly, our modeling study showed
that whereas C12-HSL and C4-HSL were predicted to
maintain interactions with Trp-60 and Asp-73, SA and
Furanone C30 were predicted to interact with Trp-60
only (Figure 7). In a follow-up study, Zou and Nair
obtained crystal structures of LasRLBD complexing TP
compounds of agonistic effect in LasR, demonstrating
that these molecules do establish hydrogen bond
interactions with Trp-60 and Asp-73 amino acids. Un-
fortunately, the authors could not demonstrate the
importance of these residues in themolecular mechan-
ism for an agonist to antagonist switching as they could
not determine the X-ray crystallographic structure of
LasRLBD bound to the antagonistic triphenyl compound
TP-5, due to instability of this complex.19
CONCLUSIONS
Upon demonstration by biochemical and biological
activity assays that the LBD of LasR receptor proteins
can fold into a functional conformation in the absence
of its cognate acyl-HSL ligand, SERS spectroscopy
allowed us to obtain direct experimental evidence of
conformational changes in LasRLBD upon interaction
with activators and inhibitors of P. aeruginosa quorum
Figure 7. Modeling of QS ligand interactions with LasRLBD. (A) Bindingmode of C12-HSL (yellow) in the recognition center of
LasR receptor (gray). Hydrogen bonding (red) and lipophilic interactions (black) are shown. (B) Comparison between the
predicted binding mode of C4-HSL (purple) and the natural autoinducer C12-HSL (yellow). (C) Plausible binding mode of SA




COSTAS ET AL. VOL. 9 ’ NO. 5 ’ 5567–5576 ’ 2015
www.acsnano.org
5574
sensing. SERS spectra indicated structural rearrange-
ments in the polypeptide that were specific to
either activators (310-helix and L3 loop) or inhibitors
(R-helices R3, R4 and/or R5). Moreover, the binding of
QSmodulators to LasRLBD influenced the interaction of
the C-terminal cysteine of the polypeptide with an
Au nanoparticle film, which thus acted as an efficient
SERS substrate to sense proteinligand interactions.
Docking studies allowed us to provide insight into the
molecular interactions between QS modulators and
LasRLBD that may be involved in the differential SERS
fingerprints obtained. As a prospect, SERS can be used
in combination with structure-based approaches to
understand proteinligand systems, thereby providing
a fast, cost-effective, and robust technique for screen-
ing interactions between proteins and drug molecules.
MATERIALS AND METHODS
Materials. Tetrachloroauric(III) acid trihydrate (HAuCl4 3 3H2O),
trisodium citrate dihydrate, poly(diallyldimethylammonium
chloride) (PDDA, average Mw 100 000200 000), hydrogen per-
oxide (H2O2, 28%) and sulfuric acid (H2SO4, 98%) were supplied
by Aldrich. N-(3-Oxododecanoyl)-L-homoserine lactone (C12-
HSL), acetylsalicylic acid (SA), (Z)-4-bromo-5-(bromomethylene)-
2(5H)-furanone (C30), HIS-Select HF Nickel affinity gel and
modifying enzymes were purchased from Sigma-Aldrich.
N-Butyryl-L-homoserine lactone (C4-HSL) was from Cayman
Chemical. Restriction enzymes were supplied by New England
Biolabs. Disuccinimidyl suberate (DSS) and Zeba Spin desalting
columns, 7k MWCO, were from Pierce. Other reagents as salts,
buffers and enzymes were acquired from Sigma-Aldrich or
Merck. All chemicals were used as received. Pure grade ethanol
and Milli-Q water were used as solvents. DNA treatment with
restriction enzymes, ligation and transformation of E. coli
were performed using standard methods. For DNA isolation,
the Spin Miniprep Kit (Qiagen) was used and DNA fragments
were excised and purified from agarose gels using the PCR
purification kit (Qiagen).
Methods. Plasmid Constructs and Protein Expression. DNA
encoding from Met-1 to Lys-173 of lasR gene was amplified




and cloned on the NdeI and HindIII sites of vector pET21a(þ)
(Novagen). The reverse primer (LasR-HindIII-6HC R) was
designed to add a hexa-histidine tag and a cysteine amino acid
residue at the C-terminus of the polypeptide. The resulting
plasmid was sequenced at the CACTI sequencing facilities
(Universidade de Vigo, Spain).
Protein Expression and Purification. The fusion protein
LasR(1173)-His6-Cys (LasRLBD) was expressed in E. coli
BL21(DE3)pLysS cells grown in LuriaBertani (LB) broth plus
100 μg/mL ampicillin, 100 μg/mL chloramphenicol and 2%
glucose until an OD600 of 0.4. The media was then replaced
with fresh LB plus antibiotics without glucose, and protein
expression was induced with 0.5 mM isopropyl 1-thio-β-D-
galactopyranoside (IPTG) at 28 C during 4 h. The bacterial
pellet was lysed in CelLytic B buffer (Sigma) supplemented with
5 mM MgCl2, 1 mM PMSF, protease inhibitor cocktail (Sigma),
and deoxyribonuclease I (Sigma-Aldrich). LasRLBD was purified
by Ni2þ affinity chromatography using the HIS-Select HF nickel
affinity gel (Sigma-Aldrich) following the commercial protocol.
Protein elution was performed using 300 mM imidazole in PBS.
The protein was desalted with Zeba Spin columns equilibrated
in 10 mM sodium phosphate buffer at pH 8.0, and the sample
was kept at 4 C for immediate use. Proteins were not stored
at 4 C for more than 1 day.
Protein Cross-Linking. Purified LasRLBD protein was preincu-
bated with 20 μM C12-HSL or the equivalent volume of ethanol
during 45 min at room temperature. When indicated, 0.5 mM
disuccinimidyl suberate (DSS) was added to the samples and
the mixtures were incubated at room temperature for 40 min.
The reaction was stopped by the addition of 20 mM Tris-HCl pH
8.0. Subsequently, samples were analyzed on a 12% SDS-PAGE
gel, and proteins were visualized by Coomassie Brilliant Blue
staining.
Quorum Sensing Reporter System and Quorum Quenching
Assay. Affinity purified apo LasRLBD (approximately 0.5 nmol)
and BSA (0.5 mmol) in PBS or PBS were incubated with 5 μM
C12-HSL for 1 h at room temperature. The mixture was subse-
quently added to a cellular suspension of MT102 E. coli bacteria
carrying pMHLAS in LB (OD600 of 0.4) and further incubated
for 90 min at 30 C to allow GFP expression. Fluorescence was
monitored using a Leica fluorescence microscope, and GFP
expression was measured at 488 nm using the EnVision ELISA
plate reader (PerkinElmer). Analysis of the functional activity of
QS ligands was performed as follows: 300 mL of bacteria grown
to an OD600 of 0.4 was incubated with 0.01 mM or 0.1 mM
C4-HSL, 0.01 mM, 0.1 mM or 1 mM SA, and 0.01 mM or 0.1 mM
C30 for 20 min at 30 C under shaking. Then, 5 μM C12-HSL was
added and bacteria were subsequently incubated for 90 min at
30 C. GFP expression was measured as previously indicated.
Synthesis and Characterization of Gold Nanoparticle Thin
Films. Citrate-stabilized AuNPs (∼60 nm in diameter) were pre-
pared by the kinetically controlled seeded growth method.47
Briefly, 150 mL of 2.2 mM trisodium citrate in Milli-Q water was
heated to boiling under vigorously stirring. After 15min, 1mL of
25 mM HAuCl4 was injected into the boiling reaction mixture,
incubated for 10 min and the reaction mixture was cooled
down to 90 C. Subsequently, 1 mL of a 25 mMHAuCl4 aqueous
solution was injected into the reaction mixture. After additional
30 min incubation, 55 mL of 60 mM sodium citrate was added.
The final solution was used as seed, and the process was
repeated again (but with just two injections of the HAuCl4
aqueous solution) six times to yield 60 nm Au NPs. Glass slides
were washed in piranha solution for 30 min and then copiously
rinsed with pure water and stored in water until use. Au NPs
films were formed by immersing the glass slides in an aqueous
PDDA solution (1 mg/mL, 0.05 M NaCl) for 15 min, rinsed with
water, dried and then immersed in the AuNPs solution for 1 day,
followed by rinsing with water. The process was repeated two
more times to obtain the final material. For substrate character-
ization, UVvis-NIR spectra were recorded using an Agilent
8453 spectrophotometer. SEM images were obtained using a
JEOL JSM-6700F FEG scanning electron microscope operating
at an acceleration voltage of 10.0 kV.
Surface-Enhanced Raman Scattering. SERS measurements
were conducted with a Renishaw InVia Reflex system. The spectro-
graph used a high-resolution grating (1800 grooves cm1) with
additional band-pass filter optics, a confocal microscope and a
2D-CCD camera. Laser excitation was carried out at 785 nm (diode)
with a 20 objective (N.A. 0.4), 4.7 mW power and 10 s acquisition
time. The substrateswere immersed in a solution of 10mMsodium
phosphate buffer at pH 8.0 containing ca. 0.5 nmol of purified
LasRLBD and incubated for 16 h at 4 C. Then, the different ligand
moleculeswere added at the indicated concentrations and incuba-
tionwascarriedout at roomtemperatureuntil SERSmeasurements.
Docking Studies. The program GOLD 5.248 was used and
protein geometries were found in the crystal structure of
the binary complex LasRLBD/C12-HSL (PDB identification code
2UV0). The receptor was used in the dimer form. The ligand and
all water molecules were removed from the crystal structure
with the exception of water molecule W2134 for docking
with ligands C12-HSL and C4-HSL. This water molecule is close
to the carbonyl group of C12-HSL side chain and seems to
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chains. Ligand geometries were minimized using the AM1
Hamiltonian as implemented in Gaussian 0949 and used as
MOL2 files. Each ligand was docked in 25 independent genetic
algorithm (GA) runs, and for each of these a maximum number
of 100 000 GA operations were performed on a single popula-
tion of 50 individuals. Operator weights for crossover, mutation
andmigration in the entry box were used as default parameters
(95, 95, and 10, respectively), as well as the hydrogen bonding
(4.0 Å) and van der Waals (2.5 Å) parameters. The position of
C12-HSL in the crystal structure was used to define the active-
site and the radius was set to 10 Å. The “flip ring corners” flag
was switched on, while all the other flags were off. The GOLD
scoring function was used to rank the ligands in order of fitness.
Conflict of Interest: The authors declare no competing
financial interest.
Acknowledgment. This work has been funded by the
European Research Council (ERC Advanced Grant #267867
Plasmaquo). We are grateful to Michael Givskov for kindly
providing the pMHLAS vector. V.L.-P. acknowledges an FPI
scholarship from the Spanish MINECO. C.G.-B. acknowledges
funding from the Spanish MINECO (SAF2013-42899-R) and
Xunta de Galicia (GRC2013-041).
Supporting Information Available: Various figures, schemes
and tables including additional SERS spectra showing stability
and reproducibility of substrates. The Supporting Information
is available free of charge on the ACS Publications website at
DOI: 10.1021/acsnano.5b01800.
REFERENCES AND NOTES
1. Moskovits, M. Surface-Enhanced Raman Spectroscopy: A
Brief Retrospective. J. Raman Spectrosc. 2005, 36, 485–496.
2. Willets, K. A.; Van Duyne, R. P. Localized Surface Plasmon
Resonance Spectroscopy and Sensing. Annu. Rev. Phys.
Chem. 2007, 58, 267–297.
3. Schlucker, S. Surface-Enhanced Raman Spectroscopy:
Concepts and Chemical Applications. Angew. Chem., Int. Ed.
2014, 53, 4756–4795.
4. Siddhanta, S.; Narayana, C. Surface Enhanced Raman Spectro-
scopy of Proteins: Implications for Drug Designing Invited
Review Article. Nanomater. Nanotechnol. 2012, 2, 1–10.
5. Ahijado-Guzman, R.; Gomez-Puertas, P.; Alvarez-Puebla,
R. A.; Rivas, G.; Liz-Marzan, L. M. Surface-Enhanced Raman
Scattering-Based Detection of the Interactions between
the Essential Cell Division Ftsz Protein and Bacterial
Membrane Elements. ACS Nano 2012, 6, 7514–7520.
6. Karthigeyan, D.; Siddhanta, S.; Kishore, A. H.; Perumal, S. S.
R. R.; Agren, H.; Sudevan, S.; Bhat, A. V.; Balasubramanyam,
K.; Subbegowda, R. K.; Kundu, T. K.; et al. SERS and MD
Simulation Studies of a Kinase Inhibitor Demonstrate the
Emergence of a Potential Drug Discovery Tool. Proc. Natl.
Acad. Sci. U.S.A. 2014, 111, 10416–10421.
7. Case, R. J.; Labbate, M.; Kjelleberg, S. Ahl-Driven Quorum-
Sensing Circuits: Their Frequency and Function among the
Proteobacteria. ISME J. 2008, 2, 345–349.
8. Galloway, W. R. J. D.; Hodgkinson, J. T.; Bowden, S. D.;
Welch, M.; Spring, D. R. Quorum Sensing in Gram-Negative
Bacteria: Small-Molecule Modulation of Ahl and Al-2
Quorum Sensing Pathways. Chem. Rev. 2011, 111, 28–67.
9. Churchill, M. E. A.; Chen, L. L. Structural Basis of Acyl-
Homoserine Lactone-Dependent Signaling. Chem. Rev.
2011, 111, 68–85.
10. Li, Z.; Nair, S. K. Quorum Sensing: How Bacteria Can
Coordinate Activity and Synchronize Their Response to
External Signals? Protein Sci. 2012, 21, 1403–1417.
11. Fuqua, C.; Greenberg, E. P. Listening in on Bacteria: Acyl-
Homoserine Lactone Signalling. Nat. Rev. Mol. Cell Biol.
2002, 3, 685–695.
12. Schuster, M.; Sexton, D. J.; Diggle, S. P.; Greenberg, E. P.
Acyl-Homoserine Lactone Quorum Sensing: From Evolu-
tion to Application. Annu. Rev. Microbiol. 2013, 67, 43–63.
13. Pesci, E. C.; Pearson, J. P.; Seed, P. C.; Iglewski, B. H.
Regulation of Las and Rhl Quorum Sensing in Pseudomo-
nas aeruginosa. J. Bacteriol. 1997, 179, 3127–3132.
14. Pearson, J. P.; Gray, K. M.; Passador, L.; Tucker, K. D.;
Eberhard, A.; Iglewski, B. H.; Greenberg, E. P. Structure of
the Autoinducer Required for Expression of Pseudomonas-
aeruginosa Virulence Genes. Proc. Natl. Acad. Sci. U.S.A.
1994, 91, 197–201.
15. Muh, U.; Hare, B. J.; Duerkop, B. A.; Schuster, M.; Hanzelka,
B. L.; Heim, R.; Olson, E. R.; Greenberg, E. P. A Structurally
Unrelated Mimic of a Pseudomonas aeruginosa Acyl-
Homoserine Lactone Quorum-Sensing Signal. Proc. Natl.
Acad. Sci. U.S.A. 2006, 103, 16948–16952.
16. Borlee, B. R.; Geske, G. D.; Blackwell, H. E.; Handelsman, J.
Identification of Synthetic Inducers and Inhibitors
of the Quorum-Sensing Regulator Lasr in Pseudomonas
aeruginosa by High-Throughput Screening. Appl. Environ.
Microbiol. 2010, 76, 8255–8258.
17. Bottomley, M. J.; Muraglia, E.; Bazzo, R.; Carfi, A. Molecular
Insights into Quorum Sensing in the Human Pathogen
Pseudomonas aeruginosa from the Structure of the
Virulence Regulator Lasr Bound to Its Autoinducer. J. Biol.
Chem. 2007, 282, 13592–13600.
18. Zou, Y. Z.; Nair, S. K. Molecular Basis for the Recogni-
tion of Structurally Distinct Autoinducer Mimics by the
Pseudomonas aeruginosa Lasr Quorum-Sensing Signaling
Receptor. Chem. Biol. 2009, 16, 961–970.
19. Kiratisin, P.; Tucker, K. D.; Passador, L. LasR, a Transcriptional
Activator ofPseudomonasaeruginosaVirulenceGenes, Func-
tions as a Multimer. J. Bacteriol. 2002, 184, 4912–4919.
20. Hentzer, M.; Riedel, K.; Rasmussen, T. B.; Heydorn, A.;
Andersen, J. B.; Parsek, M. R.; Rice, S. A.; Eberl, L.; Molin,
S.; Hoiby, N.; et al. Inhibition of Quorum Sensing in
Pseudomonas aeruginosa Biofilm Bacteria by a Halo-
genated Furanone Compound. Microbiology 2002, 148,
87–102.
21. Zhu, J.; Winans, S. C. The Quorum-Sensing Transcriptional
Regulator Trar Requires Its Cognate Signaling Ligand for
Protein Folding, Protease Resistance, and Dimerization.
Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 1507–1512.
22. Schuster, M.; Urbanowski, M. L.; Greenberg, E. P. Promoter
Specificity in Pseudomonas aeruginosa Quorum Sensing
Revealed by DNABinding of Purified LasR. Proc. Natl. Acad.
Sci. U.S.A. 2004, 101, 15833–15839.
23. Qin, Y. P.; Luo, Z. Q.; Smyth, A. J.; Gao, P.; von Bodman, S. B.;
Farrand, S. K. Quorum-Sensing Signal Binding Results in
Dimerization of Trar and Its Release from Membranes into
the Cytoplasm. EMBO J. 2000, 19, 5212–5221.
24. Welch, M.; Todd, D. E.; Whitehead, N. A.; McGowan, S. J.;
Bycroft, B. W.; Salmond, G. P. C.N-Acyl Homoserine Lactone
Binding to the Carr Receptor Determines Quorum-Sensing
Specificity in Erwinia. EMBO J. 2000, 19, 631–641.
25. Schu, D. J.; Ramachandran, R.; Geissinger, J. S.; Stevens,
A. M. Probing the Impact of Ligand Binding on the Acyl-
Homoserine Lactone-Hindered Transcription Factor Esar
of Pantoea stewartii Subsp Stewartii. J. Bacteriol. 2011, 193,
6315–6322.
26. Zhang, R. G.; Pappas, T.; Brace, J. L.; Miller, P. C.; Oulmassov,
T.; Molyneauz, J. M.; Anderson, J. C.; Bashkin, J. K.; Winans,
S. C.; Joachimiak, A. Structure of a Bacterial Quorum-
Sensing Transcription Factor Complexed with Pheromone
and DNA. Nature 2002, 417, 971–974.
27. Lintz, M. J.; Oinuma, K. I.; Wysoczynski, C. L.; Greenberg,
E. P.; Churchill, M. E. A. Crystal Structure of Qscr, a
Pseudomonas aeruginosaQuorum Sensing Signal Receptor.
Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 15763–15768.
28. Sappington, K. J.; Dandekar, A. A.; Oinuma, K. I.; Greenberg,
E. P. Reversible Signal Binding by the Pseudomonas
aeruginosa Quorum-Sensing Signal Receptor LasR. MBio
2011, 2, e00011.
29. Claussen, A.; Jakobsen, T. H.; Bjarnsholt, T.; Givskov, M.;
Welch, M.; Ferkinghoff-Borg, J.; Sams, T. Kinetic Model
for Signal Binding to the Quorum Sensing Regulator LasR.
Int. J. Mol. Sci. 2013, 14, 13360–13376.
30. Pearson, J. P.; Pesci, E. C.; Iglewski, B. H. Roles of
Pseudomonas aeruginosa Las and Rhl Quorum-Sensing
Systems in Control of Elastase and Rhamnolipid Biosynthesis




COSTAS ET AL. VOL. 9 ’ NO. 5 ’ 5567–5576 ’ 2015
www.acsnano.org
5576
31. Manefield, M.; Rasmussen, T. B.; Henzter, M.; Andersen,
J. B.; Steinberg, P.; Kjelleberg, S.; Givskov, M. Halogenated
Furanones Inhibit Quorum Sensing through Accelerated
Luxr Turnover. Microbiology 2002, 148, 1119–1127.
32. El-Mowafy, S. A.; Abd El Galil, K. H.; El-Messery, S. M.;
Shaaban, M. I. Aspirin Is an Efficient Inhibitor of Quorum
Sensing, Virulence and Toxins in Pseudomonas aeruginosa.
Microb. Pathog. 2014, 74, 25–32.
33. Yang, L.; Rybtke, M. T.; Jakobsen, T. H.; Hentzer, M.;
Bjarnsholt, T.; Givskov, M.; Tolker-Nielsen, T. Computer-
Aided Identification of Recognized Drugs as Pseudomonas
aeruginosaQuorum-Sensing Inhibitors. Antimicrob. Agents
Chemother. 2009, 53, 2432–2443.
34. Vial, S.; Pastoriza-Santos, I.; Perez-Juste, J.; Liz-Marzan, L. M.
Plasmon Coupling in Layer-by-Layer Assembled Gold
Nanorod Films. Langmuir 2007, 23, 4606–4611.
35. Backmann, N.; Zahnd, C.; Huber, F.; Bietsch, A.; Pluckthun, A.;
Lang, H. P.; Guntherodt, H. J.; Hegner, M.; Gerber, C. A Label-
Free Immunosensor Array Using Single-Chain Antibody Frag-
ments. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 14587–14592.
36. Park, K.; Lee, J. M.; Jung, Y.; Habtemariam, T.; Salah, A. W.;
Fermin, C. D.; Kim, M. Combination of Cysteine- and
Oligomerization Domain-Mediated Protein Immobilization
on a Surface Plasmon Resonance (Spr) Gold Chip Surface.
Analyst 2011, 136, 2506–2511.
37. Kogot, J. M.; England, H. J.; Strouse, G. F.; Logan, T. M. Single
Peptide Assembly onto a 1.5 nm Au Surface via a Histidine
Tag. J. Am. Chem. Soc. 2008, 130, 16156–16157.
38. Wang, H.; Levin, C. S.; Halas, N. J. Nanosphere Arrays with
Controlled Sub-10-Nm Gaps as Surface-Enhanced Raman
Spectroscopy Substrates. J. Am. Chem. Soc. 2005, 127,
14992–14993.
39. Arif, M.; Karthigeyan, D.; Siddhanta, S.; Kumar, G. V.;
Narayana, C.; Kundu, T. K. Analysis of Protein Acetyltrans-
ferase Structure-Function Relation by Surface-Enhanced
Raman Scattering (Sers): A Tool to Screen and Characterize
Small Molecule Modulators. Methods Mol. Biol. 2013, 981,
239–261.
40. Aliaga, A. E.; Aguayo, T.; Garrido, C.; Clavijo, E.; Hevia, E.;
Gomez-Jeria, J. S.; Leyton, P.; Campos-Vallette, M. M.;
Sanchez-Cortes, S. Surface-Enhanced Raman Scattering
and Theoretical Studies of the C-Terminal Peptide of the
Beta-Subunit Human Chorionic Gonadotropin without
Linked Carbohydrates. Biopolymers 2011, 95, 135–143.
41. Wei, F.; Zhang, D. M.; Halas, N. J.; Hartgerink, J. D. Aromatic
Amino Acids Providing Characteristic Motifs in the Raman
and Sers Spectroscopy of Peptides. J. Phys. Chem. B 2008,
112, 9158–9164.
42. Podstawka, E.; Ozaki, Y.; Proniewicz, L. M. Part I: Surface-
Enhanced Raman Spectroscopy Investigation of Amino
Acids and Their Homodipeptides Adsorbed on Colloidal
Silver. Appl. Spectrosc. 2004, 58, 570–580.
43. Barth, A.; Zscherp, C. What Vibrations Tell Us About
Proteins. Q. Rev. Biophys. 2002, 35, 369–430.
44. Pande, J.; Pande, C.; Gilg, D.; Vasak, M.; Callender, R.; Kagi,
J. H. R. Raman, Infrared, and Circular-Dichroism Spectro-
scopic Studies onMetallothionein;A Predominantly Turn-
Containing Protein. Biochemistry 1986, 25, 5526–5532.
45. Gullekson, C.; Lucas, L.; Hewitt, K.; Kreplak, L. Surface-
Sensitive Raman Spectroscopy of Collagen I Fibrils.
Biophys. J. 2011, 100, 1837–1845.
46. Kumar, G. V. P.; Reddy, B. A. A.; Arif, M.; Kundu, T. K.;
Narayana, C. Surface-Enhanced Raman Scattering Studies
of Human Transcriptional Coactivator P300. J. Phys. Chem.
B 2006, 110, 16787–16792.
47. Bastus, N. G.; Comenge, J.; Puntes, V. Kinetically Controlled
Seeded Growth Synthesis of Citrate-Stabilized Gold Nano-
particles of up to 200 nm: Size Focusing versus Ostwald
Ripening. Langmuir 2011, 27, 11098–11105.
48. CCDC Web page. http://www.ccdc.cam.ac.uk/products/
life_sciencies/gold/.
49. Frisch, M. J. T., G, W.; Schlegel, H. B.; Scuseria, G. E.; Robb,
M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci,
B.; Petersson, G. A.; Nakatsuji, H. et al. Gaussian 09,
Revision A.2 ed.; Gaussian, Inc.: Wallingford, CT, 2009.
A
RTIC
LE
